Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kaplan, P. W.
Right arrow Articles by Durack, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kaplan, P. W.
Right arrow Articles by Durack, D.
NEUROLOGY 1989;39:1388
© 1989 American Academy of Neurology

Reversible dementia with idiopathic hypereosinophilic syndrome

P. W. Kaplan, MB BS, MRCP, L. Waterbury, MD, C. Kawas, MD, K. Bella-Wilson, PhD and D. Durack, MB, FRCP

Department of Neurology, Francis Scott Key Medical Center and The Johns Hopkins University School of Medicine (Drs. Kaplan, Kawas, and Bolla-Wilson)
Department of Medicine, Francis Scott Key Medical Center and The Johns Hopkins University School of Medicine, Baltimore, MD (Dr. Waterbury)
Department of Medicine, Duke University Medical Center, Durham, NC. (Dr. Durack)

A 66-year-old woman with hypereosinophilic syndrome became rapidly demented. Evaluation revealed CSF eosinophilia, background slowing on EEG, and periventricular MRI abnormalities. Following steroid therapy, there was rapid resolution of the dementia and normalization of CSF and EEG. These findings support the concept of a direct neurotoxic effect on the human CNS produced either by eosinophils or possibly by eosinophil-derived neurotoxins.

Address correspondence and reprint requests to Dr. Kaplan, Department of Neurology, Francis Scott Key Medical Center, 4940 Eastern Avenue, Baltimore, MD 21224.

Received November 29, 1988. Accepted for publication in final form April 17, 1989.




This article has been cited by other articles:


Home page
BloodHome page
J. Gotlib, J. Cools, J. M. Malone III, S. L. Schrier, D. G. Gilliland, and S. E. Coutre
The FIP1L1-PDGFR{alpha} fusion tyrosine kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia: implications for diagnosis, classification, and management
Blood, April 15, 2004; 103(8): 2879 - 2891.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
M Sarazin, E Caumes, A Cohen, and P Amarenco
Multiple microembolic borderzone brain infarctions and endomyocardial fibrosis in idiopathic hypereosinophilic syndrome and in Schistosoma mansoni infestation
J. Neurol. Neurosurg. Psychiatry, February 1, 2004; 75(2): 305 - 307.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
A. M. Clarfield
The Decreasing Prevalence of Reversible Dementias: An Updated Meta-analysis
Arch Intern Med, October 13, 2003; 163(18): 2219 - 2229.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1989 by AAN Enterprises, Inc.